Format

Send to

Choose Destination
Neuro Oncol. 2018 Jan 10;20(1):4-5. doi: 10.1093/neuonc/nox169.

Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy.

Author information

1
Department of Neurology and National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany.
2
DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
3
Department of Neurology, University Hospital Mannheim, Heidelberg University, Heidelberg, Germany.
PMID:
29092058
PMCID:
PMC5761563
DOI:
10.1093/neuonc/nox169
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center